Integra LifeSciences (IART) reported $415.61 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 0.6%. EPS of $0.45 for the same period compares to $0.63 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $395.64 million, representing a surprise of +5.05%. The company delivered an EPS surprise of +4.65%, with the consensus EPS estimate being $0.43.While investors scrutinize revenue and earnings changes year-over-year and how they compare with ...